Your browser doesn't support javascript.
loading
Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-ß and epidermal growth factor receptor.
Greish, Khaled; Nehoff, Hayley; Bahman, Fatemah; Pritchard, Tara; Taurin, Sebastien.
Afiliação
  • Greish K; a Department of Molecular Medicine, and Nanomedicine Unit , College of Medicine and Medical Sciences, Princess Al-Jawhara Center for Molecular Medicine and Inherited Disorders, Arabian Gulf University , Manama , Kingdom of Bahrain.
  • Nehoff H; b Department of Oncology , Suez Canal University , Ismailia , Egypt.
  • Bahman F; c Department of Pharmacology and Toxicology , University of Otago , Dunedin , New Zealand.
  • Pritchard T; a Department of Molecular Medicine, and Nanomedicine Unit , College of Medicine and Medical Sciences, Princess Al-Jawhara Center for Molecular Medicine and Inherited Disorders, Arabian Gulf University , Manama , Kingdom of Bahrain.
  • Taurin S; d Malaghan Institute of Medical Research , Wellington , New Zealand.
J Drug Target ; 27(8): 903-916, 2019 09.
Article em En | MEDLINE | ID: mdl-30615483

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloridrato de Raloxifeno / Receptor beta de Estrogênio / Nanopartículas / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloridrato de Raloxifeno / Receptor beta de Estrogênio / Nanopartículas / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article